|
|
|
1st Australian Workshop on Cell Death
Preliminary Program
Sunday August 21st
Arrival/Registration
Monday August 22nd
Molecular Pathways in Cell Death
7:00 9:00 Breakfast
8:45 10:30 Session I: Death Receptor Signaling
Chair: John Silke
Janie Borst A genome-wide screen identifies SRP72 as a key determinant of tumor cell sensitivity to apoptosis- induction by both TRAIL Receptor-1 and -2
Bert vd Kooij TRAIL-R1 cell surface expression and pro-apoptotic activity is regulated by MARCH-8-mediated ubiquitination
Justine Hill Understanding how FLIPs inhibit death receptor-mediated apoptosis
Joane ODonnell Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak and Bax and inhibited by Bcl-2 and Mcl-1
Donia Moujalled In the presence of high levels of RIPK3, TNF can cause cell death independent of caspase 8 and RIPK1 Christelle Capini
10:30 11:00 Coffee break
11:00 12:45 Session II: Signaling
Chair: Kathy Baran
James Rickard Necroptosis mediated inflammation appears to drive Sharpincpdm/cpdm dermatitis
Najoua Lalaoui RIP1 kinase activity is required for tumour cell death induced by Smac-mimetics
Jessie Jeffrey Akt overactivity promotes spindle checkpoint bypass Yong Shen The MUC13 Cell Surface Mucin Protects Against Intestinal Inflammation by Inhibiting Epithelial Cell Apoptosis Gerry Melino p53 family, its involvement in neuronal development via miR-43a: Why we need them?
Anissa Jabour p53-dependent transcriptional responses to Interleukin-3 signaling 12:45 13:45 Lunch
13:45 15:30 Session III: Bcl-2 Family Members
Chair: Christopher Andoniou
Rogier Rooswinkel Comprehensive profiling of Bcl-2 family members in intact cells
Peter Czabotar Structures of Bcl-2 family protein complexes provide insights into the regulation of programmed cell death
Dana Wespthal The deadly shape of Bak and Bax
Colin Hockins Bax homodimerizes via a BH-3 groove:interface during apoptosis
Stefan Glaser Role of Bcl-2 family members in acute myeloid leukaemia
15:30 16:00 Coffee break
16:00 17:45 Session IV: Autophagy and Non-Apoptotic Cell Death
Chair: Sharad Kumar
Merril Curry The role of plasma membrane calcium ATPase isoforms on caspase-dependent and independent cell death
Nufail Kahn cIAP antagonists and IFNγ activate novel caspase and RIPK1 dependent death pathways
Gavin Higgins Pathways to the multiplicity of cell death outcomes in oxidatively stressed neurons
Donna Denton Autophagy and growth arrest are required for drosophila midgut cell death
Kamil Wolyniec A novel role for E6AP ubiquitin ligase in the development of B-cell lymphoma
Peter Kreuzaler STAT3 and lysosomes; partners in crime
17:45 19:30 Dinner
19:30 21:00 Funding your research. Fellowships, Grants and Companies (instead of poster session) Moderator: Nigel Waterhouse Panel: Ricky Johnstone, Sharad Kumar, John Silke, Gisela Mautner.
Tuesday August 23rd
Cell Death and Disease
7:00 9:00 Breakfast
9:00 10:30 Session V: Immunity and Disease
Chair: Michael Bots
Boris Turk Lysosomes and lysosomal proteases as mediators and/or amplifiers of cell death David Granville Extracellular granzymes: can too much cleavage be detrimental?
Dawn Cooper Granzyme K activates protease-activated receptor 1
Jenny Chia Role of perforin in human health and disease Margherita Ghisi Modulation of microRNA (MIR) Expression in human T cell Development: Targeting of Notch 3 by MIR-150 Jane Olario TBA
10:30 11:00 Coffee break
11:00 12:30 Session VI: Anti-Apoptotic Signaling
Chair: Ruth Kluck
James Vince Inhibitor of apoptosis (IAP) proteins regulate IL-1 activity
Melinda Christiensen The role of anti-apoptotic proteins in the resistance to granule-induced death by cytotoxic lymphocytes
Ueli Nachbur XIAP a double-edged sword for fatal hepatitis
Lynn Wong cIAPs and XIAP in combination negatively regulate inflammatory cytokine production and cell death in primary macrophages in a RIPK1/RIPK3 dependent manner
Jacob Qi Role of cIAP1 in protecting against ER stress-mediated apoptosis Pat Fitzgerald TBA
12:30 13:45 Lunch
13:45 20:00 Social afternoon
20:00 22:00 Dinner
Wednesday August 24rd
Cancer and Therapy
7:00 8:45 Breakfast
8:45 10:30 Session VII: Bcl-2 Family Members in Health and Disease
Chair: Grant Dewson
Delphine Mιrino Killing of lymphoid cells by ABT-737 relies exclusively on its ability to antagonize Bcl-2, not any other family member
Michaela Waibel Targeting of pro-survival Bcl-2 proteins in haematological malignancies driven by activated mutant JAK2
Livleen Kaur Definition of the cellular targets of the parapox virus Bcl-2 like protein orfv125
Kate Lawlor Differential effects of a BH3 mimetic on the induction and progression of collagen-induced arthritis
Diane Moujalled The molecular mechanisms of cAMP-induced apoptosis Alison Butt Dysregulation of apoptotic signaling impacts on the response to tamoxifen in human breast cancer cells
and predicts patient outcome and tamoxifen responsiveness in breast cancer
10:30 11:00 Coffee break
11:00 12:45 Session VIII: Cancer and Chemotherapy I
Chair: Dianne Watters
Loretta Dorstyn Physiological functions of caspase-2: as determined by the analysis of caspase-2 deficient mice and cells
Joey Puccini Aberrant DNA damage response and genomic instability in caspase-2 deficient cells
Adrian Wiegmans Inducing cell death in breast cancer by targeting DNA repair genes
Edwin Hawkins TBA
Michael Bots TBA Christine Hawkins Killing cells without inducing mutagenesis or DNA damage
12:45 14:00 Lunch
14:00 15:45 Session IX: Chemotherapy and Blood Cancers
Chair: Paul Ekert
Adele Baker Development of genetically engineered mouse models of the MLL-ENL and MLL-AF9 mutations to study tumorigenesis and identify key molecular targets for the treatment of MLL driven acute leukemia (
Rebecca Bilardi BH3 only proteins in MLL-fusion leukemia development and treatment
Gabriela Brumatti HoxA9 requires Bcl-2 to immortalize myeloid progenitors
Katrina Falkenberg Identification of novel genes involved in sensitization to histone deacetylase inhibitors
Geoff Matthews RNAi-mediated loss of HDAC3 partially phenocopies the effects of HDAC inhibitors in Eμ-myc B-cell lymphoma
Lisa Crowley Autophagy induction by Bcr-Abl expressing cells can limit efficacy of Imatinib treatment; strategies to improve treatment regimens
15:45 16:15 Coffee break
16:15 - 18:00 Session X: Immunotherapy and Immunogenicity
Chair: Christine Hawkins
Helen Beere The role of HSP70 in tumorigenesis
Alison West Anti-cancer therapy mediated by a histone deacetylase inhibitor engages the immune system
Stephen Mattarollo Immunogenic cell death elicited by chemotherapy induces innate and adaptive immunity that is critical for anti-cancer therapeutic success
Douglas Green Fueling immunity: Metabolic reprogramming in activated T lymphocytes
18:00 18:30 Coffee break
18:30 - 19:30 Round table discussion: Is Apoptosis Dead? Moderator: Alison Butt Panel: Doug Green, Gerry Melino, Janie Borst, Boris Turk
Thursday August 25th
Departure
7:00 11:00 Breakfast Departure
|